Ayurveda Market Research Report – Forecast to 2027

Ayurveda Market Information by application (medicinal, personal care), by disease pattern (respiratory system, nervous systems, gastrointestinal tract, cardiovascular system, infectious diseases, skeletal system, skin and hair), by source (vegetable, animal and mineral), by form (herbal, herbomineral, mineral), by end-users (academia and research, hospitals and clinics), by distribution (organized, over the counter) - Forecast to 2027

ID: MRFR/Pharma/4707-HCR | February 2021 | Region: Global | 100 pages

Ayurveda Market Overview


Ayurveda is an Indian system of medicine derived from “Ayurvedic” natural herbs and is a form of alternative medicine. Almost 80 percent of people in India use some form of traditional medicine, a category that includes Ayurveda. Other practicing nations include Nepal, Sri Lanka, Pakistan, and Myanmar and as such is comparable to Chinese and European traditional systems of medicine.


Drivers of Ayurveda Industry are growing awareness of the effectiveness and efficacy of traditional systems of medicine, disillusionment with modern Allopathy with its concurrent high side effects, support from Governments, increase in the R&D activities, and others. The Beijing declaration on traditional medicine by the World Health Organization has provided impetus to the adoption of traditional systems of medicine. The support from Governments is expected to pave the development of Ayurveda. For example, the Indian Government set up AYUSH ministry to promote Ayurveda and traditional systems of medicine while the Indian council of medical research is conducting molecular-based studies to validate the efficacy of Ayurveda medicines. The Indian government has also incentivized the industry by lowering the goods and service tax on Ayurveda products to only 5 % to encourage the sector. The growing eCommerce and emergence of self-learned consumers coupled with the growth of the global herbal and nutrition industry is serving the cause of the market. The clinical drivers of the Ayurveda market are growing incidence and prevalence of chronic diseases such as rheumatic disorders, cardiology, allergy and others, lower side effects associated with herbal medicines and lack of effectiveness of modern allopathy in treatment of diseases such as Hepatitis, arthritis, and others.


The lack of scientific validation for Ayurveda in developed nations such as the United States, where Ayurveda is not licensed or regulated coupled with the outlook of Ayurveda as supplementary and pseudoscience is deterring the growth of the market. The prime market constraints include lack of National Accreditation Board for Hospitals & Healthcare Providers accreditation, lack of health insurance approval, scarcity of trained workforce, and others. 


Key Vendors Operating in The Ayurveda Market


Some of the dominant vendors operating in the report are Zandu Pharmaceutical Works Ltd, Charak Pharma, Hamdard laboratories, Dabur, Baidyanath Group, Patanjali Ayurved Ltd., Vicco Labs, Emami Group and others. Dabur is the largest india-based company and has a lion’s stake in the Indian Ayurveda market.


Figure 1 Global Ayurveda Market by Applications, 2016 (% Market Share)


 Ayurveda Market by Applications


Ayurveda Market Segments


The Global Ayurveda Market Size is segmented based on application, disease pattern, source, form, end-users, distribution, and regions. Based on application, the Ayurveda market comprises of medicinal, personal care and others.


Based on disease pattern, the Ayurveda market comprises of the respiratory system, nervous systems, gastrointestinal tract, cardiovascular system, infectious diseases, skeletal system, skin and hair, others.


Based on source, the Ayurveda market comprises vegetables (leaves and fruit, seeds, roots, bark and other) and animal (oils, bones, and other). Based on form, the Ayurveda market comprises of herbal, herbomineral, mineral and others.


Based on end-users the Ayurveda market is segmented into academia and research, hospitals and clinics, over and others.


Based on distribution, the Ayurveda market is segmented into organized, over the counter and others.


Based on the regions, the Ayurveda market is segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world.


Regional Analysis


Asia Pacific region accounts for the largest share of the ayurveda market owing to their rich tradition of herbal medicines led by India, Sri Lanka, Pakistan, Indonesia, Myanmar and others. India is the largest market and accounts for almost USD 1200 million in terms of market value. India exports of Ayurvedic drugs was estimated to be around. USD 64 million in 2016. The major exports of Indian Ayurveda include Psyllium and Senna.


Russia is the second-largest ayurveda market followed by USA, Kazakhstan, UAE, Nepal, Ukraine, Japan, Philippines, Kenya and Mauritania. Europe led by France, Germany, and U.K. accounts for the third largest market due to growing demand for natural therapies and remedies. The Middle East and Africa ayurveda market is expected to be skewed in favor of Gulf economies of Saudi Arabia and UAE. The regions of Africa will also generate strong growth owing to the cost advantages of herbal medicines.


Intended Audience



  • Global Ayurveda providers, manufacturers & suppliers

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Academic institutes and universities



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2020-2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Application, Disease Pattern, Source, Form, End-users, Distribution
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Zandu Pharmaceutical Works Ltd, Charak Pharma, Hamdard laboratories, Dabur, Baidyanath Group, Patanjali Ayurved Ltd., Vicco Labs, Emami Group and others.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Growing awareness of the effectiveness and efficacy of traditional systems of medicine
  • Disillusionment with modern Allopathy with its concurrent high side effects, support from Governments
  • Increase in the R&D activities


  • Frequently Asked Questions (FAQ) :


    Ayurveda is an Indian system of medicine derived from “Ayurvedic” natural herbs and is a form of alternative medicine. Almost 80 percent of people in India use some form of traditional medicine, a category that includes Ayurveda. Other practicing nations include Nepal, Sri Lanka, Pakistan, and Myanmar and as such is comparable to Chinese and European traditional systems of medicine.

    Ayurveda market includes Charak Pharma, Zandu Pharmaceutical Works Ltd, Baidyanath Group, Hamdard laboratories, Dabur, Vicco Labs, Patanjali Ayurved Ltd., Emami Group, and others.

    Lack of scientific validation could prevent the growth of the Ayurveda market in developed regions.

    Ayurveda market would find maximum growth in the Asia Pacific region.

    The segments are nervous systems, respiratory system, cardiovascular system, infectious diseases, gastrointestinal tract, skin and hair, skeletal system, and others.

    The report includes segments like organized, over the counter, and others.

    TABLE OF CONTENT


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    Chapter 6. Global Ayurveda Market, by Source

    6.1 Introduction

    6.2 Vegetable

    6.3 Animal

    6.4 Mineral services

    Chapter 7. Global Ayurveda Market, by Disease pattern

    7.1 Introduction

    7.2 Respiratory System

    7.3 Nervous Systems

    7.4 Gastrointestinal Track

    7.5 Cardiovascular System

    7.6 Infectious Diseases

    7.7 Skeletal System

    7.8 Skin and Hair Problems

    7.9 Others

    Chapter 8. Global Ayurveda Market, by Application

    8.1 Hair Care & Fragrances

    8.2 Skin Care

    8.3 Oral Care

    8.4 Ayurvedic Medicines

    8.5 Ayurvedic Nutraceuticals

    8.6 Dietary Supplements

    8.7 Others

    Chapter 9. Global Ayurveda Market, by Form

    9.1 Introduction

    9.2 Herbal

    9.3 Herbomineral

    9.4 Mineral

    9.5 Others

    Chapter 10. Global Ayurveda Market, by Distribution

    10.1 Introduction

    10.2 Retail Sale

    10.3 Online Sale

    10.4 Over the Counter

    10.5 Others

    Chapter 11. Global Ayurveda Market, by End Users

    11.1 Introduction

    11.2 Pharmaceutical Companies

    11.3 Biotechnology Companies

    11.4 Medical Device Companies

    11.5 Food and Beverage Companies

    11.6 Others

    Chapter 12. Global Ayurveda Market, by Region

    12.1 Introduction

    12.2 America

    12.2.1 North America

    12.2.1.1 US

    12.2.1.2 Canada

    12.2.2 South America

    12.3 Europe

    12.3.1 Western Europe

    12.3.1.1 Germany

    12.3.1.2 France

    12.3.1.3 Italy

    12.3.1.4 Spain

    12.3.1.5 UK

    12.3.1.6 Rest of Western Europe

    12.3.2 Eastern Europe

    12.4 Asia-Pacific

    12.4.1 Japan

    12.4.2 China

    12.4.3 India

    12.4.4 Australia

    12.4.5 Republic of Korea

    12.4.6 Rest of Asia-Pacific

    12.5 Middle East & Africa

    12.5.1 United Arab Emirates

    12.5.2 Saudi Arabia

    12.5.3 Oman

    12.5.4 Kuwait

    12.5.5 Qatar

    12.5.6 Rest of the Middle East & Africa

    Chapter 13. Company Landscape

    13.1 Introduction

    13.2 Market Share Analysis

    13.3 Key Development & Strategies

    13.3.1 Key Developments

    Chapter 14 Company Profiles

    14.1 Amrutanjan Health Care Ltd.

    14.1.1 Company Overview

    14.1.2 Type Overview

    14.1.3 Financials

    14.2.4 Key Developments

    14.1.5 SWOT Analysis

    14.2 Zandu Pharmaceuticals Works Ltd.

    14.2.1 Company Overview

    14.2.2 Type Overview

    14.2.3 Financial Overview

    14.2.4 Key Developments

    14.2.5 SWOT Analysis

    14.3 WELEX Laboratories Pvt. Ltd

    14.3.1 Company Overview

    14.3.2 Type Overview

    14.3.3 Financial Overview

    14.3.4 Key Development

    14.3.5 SWOT Analysis

    14.4 Lotus Herbals

    14.4.1 Company Overview

    14.4.2 Type/Business Segment Overview

    14.4.3 Financial Overview

    14.4.4 Key Development

    14.4.5 SWOT Analysis

    14.5 Khadi Natural

    14.5.1 Company Overview

    14.5.2 Type Overview

    14.5.3 Financial overview

    14.5.4 Key Developments

    14.5.5 SWOT Analysis

    14.6 Surya Herbal Ltd.

    14.6.1 Company Overview

    14.6.2 Type Overview

    14.6.3 Financial Overview

    14.6.4 Key Developments

    14.6.5 SWOT Analysis

    14.7 Maxcure Nutracedics Ltd.

    14.7.1 Overview

    14.7.2 Type Overview

    14.7.3 Financials

    14.7.4 Key Developments

    14.7.5 SWOT Analysis

    14.8 Dabur India Ltd.

    14.8.1 Overview

    14.8.2 Type Overview

    14.8.3 Financials

    14.8.4 Key Developments

    14.8.5 SWOT Analysis

    14.9 AVA Products & Services

    14.9.1 Overview

    14.9.2 Type Overview

    14.9.3 Financials

    14.9.4 Key Developments

    14.9.5 SWOT Analysis

    14.10 Vicco Laboratories

    14.10.1 Overview

    14.10.2 Type Overview

    14.10.3 Financials

    14.10.4 Key Developments

    14.10.5 SWOT Analysis

    14.11 The Himalaya Drug Company

    14.11.1 Overview

    14.11.2 Type Overview

    14.11.3 Financials

    11.11.4 Key Developments

    14.11.5 SWOT Analysis

    14.12 Patanjali Ayurved Limited

    14.12.1 Overview

    14.12.2 Type Overview

    14.12.3 Financials

    14.12.4 Key Developments

    14.12.5 SWOT Analysis

    14.13 Others

    Chapter 15 Appendix

    LIST OF TABLES

    Table 1 Global Ayurveda Market, Industry Synopsis, 2020–2027

    Table 2 Global Ayurveda Market, Estimates & Forecast, 2020–2027, (USD Million)

    Table 3 Global Ayurveda Market, by Region, 2020–2027, (USD Million)

    Table 4 Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table 5 Global Ayurveda Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 6 Global Ayurveda Market, by Application, 2020 –2027, (USD Million)

    Table 7 Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 8 Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 9 Global Ayurveda Market, by End Users, 2020–2027, (USD Million)

    Table 10 North America: Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table11 North America: Global Ayurveda Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 12 North America: Global Ayurveda Market, by Application, 2020 –2027, (USD Million)

    Table 13 North America: Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 14 North America: Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 15 North America: Global Ayurveda Market, by End Users, 2020–2027, (USD Million)

    Table 16 US: Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table 17 US: Global Ayurveda Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 18 US: Global Ayurveda Market, by Application, 2020 –2027, (USD Million)

    Table 19 US: Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 20 US: Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 21 US: Global Ayurveda Market, by End Users, 2020–2027, (USD Million)

    Table 22 Canada: Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table 23 Canada: Global Ayurveda Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 24 Canada: Global Ayurveda Market, by Application, 2020 –2027, (USD Million)

    Table 25 Canada: Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 26 Canada: Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 27 Canada: Global Ayurveda Testing Market, by End Users, 2020–2027, (USD Million)

    Table 28 South America: Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table 29 South America: Global Ayurveda Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 30 South America: Global Ayurveda Testing Market, by Application, 2020 –2027, (USD Million

    Table 31 South America: Global Ayurveda Testing Market, by Form, 2020–2027, (USD Million)

    Table 32 South America: Global Ayurveda Testing Market, by Distribution, 2020–2027, (USD Million)

    Table 33 South America: Global Ayurveda Testing Market, by End Users, 2020–2027, (USD Million)

    Table 34 Europe: Global Ayurveda Testing Market, Source, 2020–2027, (USD Million)

    Table 35 Europe: Pyrogen Testing Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 36 Europe: Pyrogen Testing Market, by Application, 2020 –2027, (USD Million)

    Table 37 Europe: Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 38 Europe: Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 39 Europe: Global Ayurveda Market, by End Users, 2020–2027, (USD Million)

    Table 40 Western Europe: Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table 41 Western Europe: Global Ayurveda Market, by Disease pattern ,2020 –2027, (USD Million)

    Table 42 Western Europe: Global Ayurveda Market, by Application,2020 –2027, (USD Million)

    Table 43 Western Europe: Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 44 Western Europe: Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 45 Western Europe: Global Ayurveda Market, by End Users, 2020–2027, (USD Million)

    Table 46 Eastern Europe: Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table 47 Eastern Europe: Global Ayurveda Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 48 Eastern Europe: Global Ayurveda Market, by Patent Type, 2020 –2027, (USD Million)

    Table 49 Eastern Europe: Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 50 Eastern Europe: Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 51 Eastern Europe: Global Ayurveda Market, by End Users, 2020–2027, (USD Million)

    Table 52 Asia-Pacific: Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table 53 Asia-Pacific: Global Ayurveda Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 54 Asia-Pacific: Global Ayurveda Market, by Application, 2020 –2027, (USD Million)

    Table 55 Asia-Pacific: Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 56 Asia-Pacific: Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 57 Asia-Pacific: Global Ayurveda Market, by End Users, 2020–2027, (USD Million)

    Table 58 Middle East & Africa: Global Ayurveda Market, by Source, 2020–2027, (USD Million)

    Table 59 Middle East & Africa: Global Ayurveda Market, by Disease pattern, 2020 –2027, (USD Million)

    Table 60 Middle East & Africa: Global Ayurveda Market, by Application, 2020 –2027, (USD Million)

    Table 61 Middle East & Africa: Global Ayurveda Market, by Form, 2020–2027, (USD Million)

    Table 62 Middle East & Africa: Global Ayurveda Market, by Distribution, 2020–2027, (USD Million)

    Table 63 Middle East & Africa: Global Ayurveda Market, by End Users, 2020–2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Application

    Figure 2 Market structure for the Global Ayurveda Market

    Figure 3 Market Dynamics for the Global Ayurveda Market

    Figure 4 Global Ayurveda Market Share, by Source 2020

    Figure 5 Global Ayurveda Market Share, by Disease pattern, 2020

    Figure 6 Global Ayurveda Market Share, by Application, 2020

    Figure 7 Global Ayurveda Market Share, by Form, 2020

    Figure 8 Global Ayurveda Market Share, by Distribution, 2020

    Figure 9 Global Ayurveda Market Share, by End Users, 2020

    Figure 10 Global Ayurveda Market Share, by Region, 2020

    Figure 11 North America Global Ayurveda Market Share, by Country, 2020

    Figure 12 Europe Prescribed Health Apps Share, by Country, 2020

    Figure 13 Asia-Pacific Global Ayurveda MarketShare, by Country, 2020

    Figure 14 Middle East & Africa Global Ayurveda Market Share, by Country, 2020

    Figure 15 Global Ayurveda Market: Company Share Analysis, 2020 (%)

    Figure 16 Amrutanjan Health Care Ltd.: Key Financials

    Figure 17 Amrutanjan Health Care Ltd.: Segmental Revenue

    Figure 18 Amrutanjan Health Care Ltd.: Geographical Revenue

    Figure 19 Zandu Pharmaceuticals Works Ltd.: Key Financials

    Figure 20 Zandu Pharmaceuticals Works Ltd.: Segmental Revenue

    Figure 21 Zandu Pharmaceuticals Works Ltd.: Geographical Revenue

    Figure 22 WELEX Laboratories Pvt. Ltd: Key Financials

    Figure 23 WELEX Laboratories Pvt. Ltd: Segmental Revenue

    Figure 24 WELEX Laboratories Pvt. Ltd: Geographical Revenue

    Figure 25 Lotus Herbals: Key Financials

    Figure 26 Lotus Herbals: Segmental Revenue

    Figure 27 Lotus Herbals: Geographical Revenue

    Figure 28 Khadi Natural: Key Financials

    Figure 29 Khadi Natural: Segmental Revenue

    Figure 30 Khadi Natural: Geographical Revenue

    Figure 31 Surya Herbal Ltd.: Key Financials

    Figure 32 Surya Herbal Ltd.: Segmental Revenue

    Figure 33 Surya Herbal Ltd.: Geographical Revenue

    Figure 34 Maxcure Nutracedics Ltd.: Key Financials

    Figure 35 Maxcure Nutracedics Ltd.: Segmental Revenue

    Figure 36 Maxcure Nutracedics Ltd.: Geographical Revenue

    Figure 37 Dabur India Ltd.: Key Financials

    Figure 40 Dabur India Ltd.: Segmental Revenue

    Figure 41 Dabur India Ltd.: Geographical Revenue

    Figure 42 AVA Products & Services: Key Financials

    Figure 43 AVA Products & Services: Segmental Revenue

    Figure 44 AVA Products & Services: Geographical Revenue

    Figure 45 Vicco Laboratories: Key Financials

    Figure 46 Vicco Laboratories: Segmental Revenue

    Figure 47 Vicco Laboratories: Geographical Revenue

    Figure 48 The Himalaya Drug Company: Key Financials

    Figure 49 The Himalaya Drug Company: Segmental Revenue

    Figure 50 The Himalaya Drug Company: Geographical Revenue

    Figure 51 Patanjali Ayurved Limited: Key Financials

    Figure 52 Patanjali Ayurved Limited: Segmental Revenue

    Figure 53 Patanjali Ayurved Limited: Geographical Revenue